Analyze Diet

Topic:Pharmacology

Pharmacology in horses involves the study and application of drugs and medications to diagnose, treat, and prevent diseases and conditions in equine species. This field encompasses the understanding of pharmacokinetics and pharmacodynamics specific to horses, including how drugs are absorbed, distributed, metabolized, and excreted by the equine body. Commonly studied pharmacological agents in horses include non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, sedatives, and anthelmintics. Research in equine pharmacology focuses on determining appropriate dosages, understanding drug interactions, and minimizing adverse effects. This page compiles peer-reviewed research studies and scholarly articles that investigate the efficacy, safety, and regulatory aspects of pharmacological interventions in equine veterinary practice.
Vonoprazan pharmacokinetics and effects on gastric pH following administration to fed and fasted horses.
Equine veterinary journal    January 14, 2026   doi: 10.1111/evj.70128
Morales CJ, Sykes BW, McKemie DS, Kass PH, Knych HK.Current treatment options for equine gastric ulcer syndrome (EGUS), such as omeprazole-a proton pump inhibitor (PPI)-have notable limitations, including the need for administration on an empty stomach. Potassium-competitive acid blockers (P-CABs), such as vonoprazan, are a newer class of acid suppressants that offer several advantages over PPIs in humans and may provide similar benefits in horses. Objective: To describe the pharmacokinetics and effect of a single oral dose of vonoprazan on intragastric pH in horses. We hypothesised that vonoprazan would follow linear kinetics across the doses ...
Enrofloxacin induces mild and transient vascular alterations following regional limb perfusion in horses.
Journal of equine veterinary science    January 6, 2026   Volume 158 105777 doi: 10.1016/j.jevs.2026.105777
Valente TC, Mendes RP, Miguel EL, Rafael LA, Ribeiro GSN, Souza AF, Fonteque JH.Regional intravenous limb perfusion (RILP) is widely used in equine practice for achieving high local antimicrobial concentrations while minimizing systemic exposure. However, certain drugs, including enrofloxacin, have been associated with vascular irritation and thrombosis, and their thrombogenic potential remains poorly characterized. Objective: This study aimed to evaluate the thrombogenic potential of enrofloxacin administered via RILP in the cephalic vein of clinically healthy horses. Methods: Ten adult horses underwent RILP in both forelimbs: the right limb received 10 % enrofloxacin (1...
Anti-Theileria equi activity of methanolic extract of Artemisia scoparia: In vitro efficacy, in vivo safety, and identification of lead molecules.
Veterinary parasitology    January 6, 2026   Volume 343 110695 doi: 10.1016/j.vetpar.2026.110695
Gupta KK, Singh L, Saxena N, Dey S, Kumar R, Kumar S.Equine piroplasmosis is a tick-borne disease that affects horses and is caused by Theileria equi and Babesia caballi. Currently, imidocarb dipropionate is the primary treatment for T. equi infections; however, its application is limited by its potential systemic toxicity. Artemisia annua is widely recognised for its antimalarial properties, whereas Artemisia scoparia has traditionally been used for various medicinal purposes. However, the therapeutic potential of A. scoparia against theileriosis in animals remains largely unknown. Activity-guided fractionation of a methanolic extract of A. sco...
Evaluation of a nutraceutical for prevention of equine ulcer recurrence.
Equine veterinary journal    December 30, 2025   doi: 10.1002/evj.70143
Hansen S, Tecles F, Cerón JJ, From C, Carstensen H, Muñoz-Prieto A.The number of horses with equine squamous gastric disease (ESGD) and equine gastric glandular disease (EGGD) recurrence when pharmacological treatment is discontinued is high. Objective: To examine if a commercially available nutraceutical compound containing lecithin, pectin, and meadowsweet could prevent recurrence of both ESGD and EGGD after omeprazole treatment, evaluated by repeated gastroscopic examinations and saliva biomarkers. Methods: Blinded, randomised, placebo-controlled clinical trial. Methods: Thirty horses of mixed breeds and sex with a recent diagnosis and treatment of both ES...
Effect of transdermal melatonin on circulating cortisol and blood chemistry in horses exposed to transport stress.
Journal of equine veterinary science    December 26, 2025   Volume 157 105756 doi: 10.1016/j.jevs.2025.105756
Crossland WL, Aviles-Rosa EO, Perry EB, Crowell C, Webberson E, Brown J, Fassbender J.Our objective was to evaluate the effect of transdermal melatonin on physiological stress biomarkers in horses, with some subjected to transport stress. Sixteen horses were assigned to a 2 × 2 factorial design assessing treatment (melatonin vs. no melatonin) and transport status (transported vs. non-transported), creating four groups: Control (CON), Transport only (TRS), Melatonin only (MEL), and Melatonin plus Transport (MELTRS). Horses in melatonin groups received 24 mg/day transdermally for 21 days and transported groups underwent a 3-hour trailer ride on day 21. Day 21 blood samples were ...
Equine trypanosomiasis, a systematic review: Disease management.
Equine veterinary journal    December 22, 2025   Volume 58, Issue 2 320-332 doi: 10.1002/evj.70136
Raftery AG, Gummery L, Garcia K, Mohite D, Capewell P, Sutton D.Equine trypanosomiasis is a neglected protozoal disease. Objective: To answer the study question: In equines what are the effects of disease management of trypanosomiasis on disease severity (individual level) and disease prevalence (population level) compared to no intervention? Methods: Systematic review. Methods: Studies were identified that described management of naturally occurring equine trypanosomiasis in any country following 'Preferred Reporting Items for Systematic Reviews and Meta-analyses' using eight international databases (1980-2022). Risk of bias was assessed using ROBINS-I. D...
Sodium-glucose transporters SGLT1 and SGLT2 in equine renal, hepatic and pancreatic tissue.
BMC veterinary research    December 17, 2025   Volume 22, Issue 1 36 doi: 10.1186/s12917-025-05173-1
Anger-Håål C, Fjordbakk CT, Ekstrand C, Skedsmo FS, Rørtveit R.Insulin dysregulation is a hallmark of equine metabolic syndrome (EMS), and in recent years, pharmacological treatment with sodium-dependent glucose transporter 2 inhibitors (SGLT2i) have shown promise in reducing the risk of hyperinsulinemia-associated laminitis in horses diagnosed with EMS. In humans and laboratory animals, this transporter protein is responsible for the majority of renal tubular glucose reabsorption, however, the presence of this and the related sodium-dependent glucose transporter 1 (SGLT1) have not yet been studied in equine kidneys. Additionally, studies in humans and la...
Pharmacokinetics of a fipronil pour-on formulation and its efficacy against Dermacentor nitens (Acari: Ixodidae) in horses.
Veterinary parasitology    December 8, 2025   Volume 342 110674 doi: 10.1016/j.vetpar.2025.110674
da Silva Rocha MB, Avelar BR, Martins Dos Santos GC, Ferreira TP, de Sousa Vieira T, de Oliveira GF, Gomes BT, Klafke GM, Correia TR, Cid YP, Scott FB.The objective of this study was to standardize a stall-trial methodology for horses in order to evaluate the pharmacokinetics and efficacy of a 1 % fipronil pour-on formulation against Dermacentor nitens. Brazilian pony breed horses were housed in individual stalls within a covered barn and artificially infested with D. nitens larvae on alternate days from day -31 to -1 before treatment. The animals were treated on day 0 with a fipronil 1 % pour-on at a dose of 1 mg/Kg body weight. To determine the therapeutic efficacy, the number of engorged females naturally detached from control and t...
Evaluation of the impact of acepromazine on tissue oxygenation in horses sedated with detomidine.
Research in veterinary science    December 6, 2025   Volume 200 106019 doi: 10.1016/j.rvsc.2025.106019
James AL, Vettorato E, Moura RA, Azevedo TMBPR, Mallicote MF, Chiavaccini L.Sedation with α₂-agonists can impair microcirculation and oxygen delivery. This prospective randomized crossover study investigated whether administering acepromazine maleate before detomidine hydrochloride maintains higher peripheral tissue oxygen saturation (StO₂) in sedated horses. Eight healthy adult horses randomly received intravenous detomidine (10 μg/kg) either alone (D) or in combination with acepromazine (20 μg/kg; DA), with a one-week washout. Hemoglobin concentration and central venous oxygen saturation (ScvO₂) were measured at baseline. Tissue oxygen saturation, tissue ...
Pharmacokinetics and Safety of a Single Subcutaneous or Intramuscular Dose of Ketamine in Healthy Horses.
Journal of veterinary pharmacology and therapeutics    December 3, 2025   Volume 49, Issue 2 141-149 doi: 10.1111/jvp.70037
Rangel A, Sellon DC, Sanz MG, Pinnell E, Pietras ZM, Villarino NF.Pharmacokinetics (PK) of intramuscular (IM) and subcutaneous (SC) ketamine in horses has not been described. This study aimed to evaluate the PK and safety of ketamine and its metabolites after a single SC or IM administration. In Phase 1, two horses received 0.5 or 1 mg/kg of ketamine via SC and IM routes. In Phase 2, eight horses received 0.5 mg/kg IM. Plasma or serum concentrations of ketamine and major metabolites were determined by a validated liquid chromatography-mass spectrometry method at baseline and selected intervals post-administration. Subcutaneous administration resulted in ...
Metformin Protects Against Persistent Atrial Fibrillation in an Equine Model.
Circulation. Arrhythmia and electrophysiology    December 2, 2025   Volume 18, Issue 12 e013850 doi: 10.1161/CIRCEP.125.013850
Haugaard SL, Schneider MJ, Kjeldsen ST, Sattler SM, Bastrup JA, Saljic A, Birk JB, Hansen C, Synnestvedt JN, van Hunnik A, Sobota V, Carstensen H....Horses are one of the few animals that spontaneously develop atrial fibrillation (AF), making them a powerful model for studying AF mechanisms and treatment effects. Despite the initial effectiveness of treatment in horses and humans, AF-induced atrial remodeling compromises its long-term success. Observational studies have suggested that metformin may reduce the risk of AF, but its effects on progressive AF-induced atrial remodeling have yet to be evaluated in a high-fidelity large animal model. Unassigned: Here, we used a longitudinal horse model of tachypacing-induced self-sustained AF to c...
Physiological and behavioural effects of continuous remifentanil-xylazine administration in donkeys.
Equine veterinary journal    November 27, 2025   doi: 10.1111/evj.70131
Damasceno KFA, Mouta AN, Alves LSA, Arcoverde KN, Aragão HR, Cavalcante JM, Veras de Paula V.Remifentanil and xylazine are used as continuous infusions to facilitate standing surgery in horses. Their use for this purpose has not been reported in donkeys. Objective: To evaluate the behavioural, sedative, and cardiorespiratory effects of continuous intravenous infusion of remifentanil and xylazine in donkeys. Methods: Non-blinded in vivo experiments. Methods: Ten donkeys were sedated with an intravenous bolus of xylazine (0.8 mg/kg). After 3 min, continuous infusions of xylazine (0.65 mg/kg/h) and remifentanil (6 μg/kg/h) were administered for 60 min. Cardiorespiratory physio...
Oral administration of pimobendan in healthy horses results in low plasma concentrations.
American journal of veterinary research    November 24, 2025   Volume 87, Issue 2 ajvr.25.08.0302 doi: 10.2460/ajvr.25.08.0302
Jula CA, Davis JL, McKenzie HC, Council-Troche M.To describe the pharmacokinetics of a single dose of pimobendan (Vetmedin) in healthy adult horses and provide preliminary evidence of the absorption of 2 compounded pimobendan formulations. Unassigned: From August 2022 through November 2022, 6 healthy adult horses were administered a single dose of 0.5 mg/kg pimobendan orally. A subset of 2 horses was also administered pimobendan, compounded as an oil-based suspension and a capsule formulation. Plasma was collected at times 0, 15, 30, and 45 minutes and 1, 2, 4, 8, 12, and 24 hours after administration. The plasma concentrations of pimobendan...
Liposomal bupivacaine caudal epidural in horses results in adverse effects without analgesia.
Veterinary surgery : VS    November 20, 2025   Volume 55, Issue 1 218-224 doi: 10.1111/vsu.70055
Stokes C, Natalini CC, Wills R, Eddy A, Mochal-King C, O'Shea C, Fontenot RL.To evaluate the analgesic properties and adverse effects of liposomal bupivacaine administered via caudal epidural in horses. Methods: Pharmacodynamic study. Methods: A total of 10 healthy adult horses. Methods: Liposomal bupivacaine (10 mL; 1.3%) was administered into the caudal epidural space via an indwelling epidural catheter inserted to a length of 15 cm. Mechanical nociceptive threshold (MNT) testing with pressure algometry was used to measure analgesia at four anatomic locations for 72 h following injection. Physical examinations (including rectal temperature, heart rate, respirat...
Effects of Lidocaine Alone Versus Lidocaine-Dexmedetomidine Infusion on Pulmonary Gas Exchange and Respiratory Mechanics During Isoflurane Anesthesia in Horses.
Veterinary sciences    November 16, 2025   Volume 12, Issue 11 1089 doi: 10.3390/vetsci12111089
Chiavaccini L, Moura RA, Azevedo TMBPR, De Gennaro C, Vettorato E, Romano M, Portela DA.Dexmedetomidine improves pulmonary function in dogs and humans, but evidence in horses is scarce. This study evaluated dexmedetomidine infusion on oxygenation and respiratory mechanics in anesthetized horses. Twenty horses undergoing elective surgery were included in a prospective, non-randomized, observational study. Horses received either lidocaine alone (1.3 mg/kg over 15 min, then 3 mg/kg/hour; LIDO) or combined with dexmedetomidine (1.75 μg/kg over 15 min, then 1.75 μg/kg/hour; DL). Respiratory mechanics, gas exchange, and cardiovascular variables were recorded at baseline, post-loading...
Effects of clodronate disodium on markers of inflammation and cartilage metabolism in juvenile horses challenged with intra-articular lipopolysaccharide.
Journal of animal science    November 12, 2025   Volume 103 skaf393 doi: 10.1093/jas/skaf393
George JM, Leatherwood JL, Paris BL, Arnold CE, Glass KG, Conrad MB, Martinez RE, Vergara-Hernandez FB, Nielsen BD, Colbath AC, Welsh TH, Bradbery AN.Perceived chondroprotective and anti-inflammatory benefits of bisphosphonates in the juvenile horse has led to extra-label use without supportive data regarding intra-articular effects on cartilage metabolism and inflammation. Thirty-two yearling Quarter Horses were stratified into 4 treatment groups by age (500 ± 13 d), BW (336 ± 26 kg), sex (n = 16 female; n = 16 male) and initial bone optical density for a 140-d study. The study consisted of two exercise phases: Phase 1 (d 0-84) emulated sales preparation and Phase 2 (d 99-140) mimicked early exercise training. Horses we...
Inhibition of interleukin-1 receptor-associated kinase (IRAK)-4 provides partial rescue of interleukin-1 beta induced functional and gene expression changes in equine tenocytes.
Molecular biology reports    November 6, 2025   Volume 53, Issue 1 54 doi: 10.1007/s11033-025-11219-2
Beaumont RE, Flood C, Guest DJ.Interleukin 1 beta (IL-1β) is upregulated following a tendon injury and in vitro studies have shown that it leads to numerous negative effects on tendon cell function and gene expression. IL-1β activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and we hypothesised that inhibiting NF-κB activation would mediate the negative effects of IL-1β on equine tendon cells in 3-dimensional (3D) cultures. Results: Here, we tested three inhibitors of NF-κB signalling (Bortezomib, BAY11-7082 and Wedelolactone) along withTJ-M2010-5, an inhibitor of MyD88, which is a critic...
Metabolism, pharmacokinetics, and bioavailability of cannabigerol in horses following intravenous and oral administration with micellar and oil formulations.
Frontiers in veterinary science    October 29, 2025   Volume 12 1688214 doi: 10.3389/fvets.2025.1688214
Serrano-Rodríguez JM, Miraz R, Saitua A, Díez de Castro E, Ledesma-Escobar C, Ferreiro-Vera C, Priego-Capote F, Sánchez de Medina V....Cannabigerol (CBG) is a non-psychoactive cannabinoid with growing interest in veterinary medicine; however, its pharmacokinetic profile in horses remains unknown. Understanding its absorption, distribution, metabolism, and elimination is essential to optimizing dosing strategies and evaluating its potential for clinical use in equine patients. Unassigned: A prospective crossover study was conducted in eight healthy adult horses to assess the metabolism and the pharmacokinetics after intravenous (IV) administration at 1 mg/kg and oral administrations at 10 mg/kg with two formulations (mice...
A Meta-Analysis of International Flunixin Pharmacokinetics in Horses: Toward Regulatory Harmonization and Individualized Detection Times Using Bayesian Paradigm.
Drug testing and analysis    October 25, 2025   Volume 18, Issue 1 32-50 doi: 10.1002/dta.3961
Kuroda T, Knych HK, Noble GK, Minamijima Y, Leung GN, Nomura M, Mizobe F, Ishikawa Y, Kusano K, Toutain PL.Flunixin meglumine is widely used to manage pain and inflammation in horses, and its regulation requires robust pharmacokinetic analysis for harmonization. In this study, we conducted a meta-analysis of flunixin disposition using plasma and urine concentration data from 65 horses across four countries to robustly estimate pharmacokinetic parameters in setting screening limits (SLs) for controlling medications in horses. A population (POP) model was developed using nonlinear mixed-effects model analysis. The irrelevant plasma concentration (IPC) and irrelevant urine concentration (IUC) were det...
Impact of sequential administration of detomidine, butorphanol, and midazolam on sedation, ataxia, stimulus response, and bispectral index in horses.
Frontiers in veterinary science    October 23, 2025   Volume 12 1691137 doi: 10.3389/fvets.2025.1691137
Thorn CA, Wilson DV, Wang S, Horne WA.Standing sedation is a safe and cost-effective alternative to general anesthesia in horses, but challenges include achieving adequate drug effect to block the stimulus response without inducing ataxia or recumbency. A benefit of midazolam has been reported in equine dental procedures. Seeking synergy, a combination of lower doses of several pharmacologic agents, including midazolam, may improve the quality of sedation while minimizing adverse effects. Bispectral index (BIS) correlates with sedation scores in human ICU patients, but the correlation between sedation scores and BIS has not been e...
Bioanalytical Uncertainty Assessment of Ultra-High-Performance Liquid Chromatography-High Resolution Mass Spectrometry Method for Caffeine and Lidocaine in Equine Antidoping: A Dual Perspective on Bottom-up and Top-Down Approaches.
Journal of separation science    October 23, 2025   Volume 48, Issue 10 e70308 doi: 10.1002/jssc.70308
El-Ghaly W, El Kamli T, Zaari Lambarki L, El Hamdani M, Lahkak FE, Benmoussa A, Balouch L, Bakkali F, Saffaj T, Jhilal F.The quality of quantitative results in bioanalysis requires not only a validated analytical method but also a rigorous estimation of measurement uncertainty. This study examines the challenges associated with the implementation of two distinct approaches in equine anti-doping control for the assessment of uncertainty associated with an ultra-high-performance liquid chromatography-high resolution mass spectrometry quantitative method for caffeine and lidocaine in horse urine. The bottom-up approach, based on the ISO Guide to the Expression of Uncertainty in Measurement (ISO GUM), was compared t...
Incorporating a Behavioral Medicine Approach in the Multi-Modal Management of Chronic Equine Gastric Ulcer Syndrome (EGUS): A Clinical Commentary.
Animals : an open access journal from MDPI    October 17, 2025   Volume 15, Issue 20 3019 doi: 10.3390/ani15203019
Klinck M, Lovett A, Sykes B.Equine gastric ulcer syndrome (EGUS) refers to mucosal gastric disease in horses, including equine squamous gastric disease (ESGD) and equine glandular gastric disease (EGGD), which present as two distinct disease entities differing in pathophysiology and approach to disease management. Both diseases are a source of pain in affected horses, partly explaining why EGUS continues to receive substantial attention in the equine medical, welfare and equitation research sectors. There is a complex interplay between EGUS and a variety of physical and psychological stressors. Horses with EGUS are often...
Effect of N-Butylscopolammonium Bromide and Metamizol Sodium on Heart Rate, Blood Pressure, and Echocardiographic Measurements in Warmblood Horses With Aortic and Mitral Valve Regurgitation.
Journal of veterinary internal medicine    October 10, 2025   Volume 39, Issue 6 e70254 doi: 10.1111/jvim.70254
Dufourni A, Demeyere M, Vernemmen I, Van Steenkiste G, Verhaeghe LM, van Loon G, Decloedt A.Administration of N-butylscopolammonium bromide (NBB) with metamizol sodium (NBBM) causes tachycardia and hypertension, and has been associated with accentuated cardiac murmurs. Objective: To evaluate the effect of a pharmacological challenge using NBBM on valvular regurgitation and cardiac murmurs in horses with aortic (AR) and mitral valve regurgitation (MR). Methods: Twenty Warmblood horses with AR and 20 with MR. Methods: Cardiac auscultation and two-dimensional (2D), M-mode, color flow, pulsed wave Doppler flow, and tissue Doppler echocardiography were performed with simultaneous ECG reco...
Effects of the Sodium-Glucose Cotransporter-2 Inhibitor Velagliflozin on Insulin Concentrations in Horses With Insulin Dysregulation.
Journal of veterinary internal medicine    October 9, 2025   Volume 39, Issue 6 e70256 doi: 10.1111/jvim.70256
Thane K, Voth R, Klee R, Warnken T, Chukwu V, Frank N.Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are promising treatments to manage hyperinsulinemia in horses with insulin dysregulation (ID). Objective: The SGLT2i velagliflozin decreases insulin concentration in horses with ID. Methods: Privately-owned adult horses (n = 37) with laboratory-confirmed ID (low-dose oral sugar test insulin concentration > 75 μIU/mL). Methods: Double-blind randomized placebo-controlled trial. Horses received placebo (n = 19) or velagliflozin 0.3 mg/kg PO q24h (n = 18) for 20 weeks (Study Period 1, SP1) immediately followed by a 20-week ...
Antimicrobial use in equine patients at a veterinary teaching hospital in the northeastern United States reveals opportunities for enhanced stewardship.
Journal of the American Veterinary Medical Association    October 8, 2025   Volume 264, Issue 2 1-8 doi: 10.2460/javma.25.06.0373
Velarde PS, Cummings KJ, LaPointe C, Perkins GA.To assess the use of systemic antimicrobial agents in equine patients and identify areas where their use could be reduced. Unassigned: A retrospective study evaluating the electronic medical records for all equine visits in which systemic antimicrobials were given at a veterinary teaching hospital for 1 year (2021). Negative binomial regression analysis was used to evaluate factors associated with antimicrobial prescription rate. Unassigned: Systemic antimicrobials were prescribed for 33.5% (543 of 1,622) of equine visits. For most visits (89.1%), ≤ 3 antimicrobials were given. The antimicro...
Adverse Effects of Antimicrobial Drugs Use in Horses.
The Veterinary clinics of North America. Equine practice    October 6, 2025   Volume 41, Issue 3 633-651 doi: 10.1016/j.cveq.2025.08.010
Gomez DE, Johnson JP.Antimicrobial drug therapy in horses can lead to adverse effects across multiple body systems, with specific age groups, such as foals, at particular risk. Certain antimicrobial drugs, such as penicillins, aminoglycosides, macrolides, tetracyclines, and trimethoprim-sulfonamide combinations, are commonly implicated. This review explores the mechanisms behind these adverse reactions, emphasizing the importance of judicious antimicrobial drug use. This review also underscores the need for a centralized pharmacovigilance system to improve drug safety and adverse event reporting for veterinary med...
In Vitro Effects of PRP, Ozonized PRP, Hyaluronic Acid, Paracetamol, and Polyacrylamide on Equine Synovial Fluid-Derived Mesenchymal Stem Cells.
Life (Basel, Switzerland)    October 4, 2025   Volume 15, Issue 10 1558 doi: 10.3390/life15101558
Bungărdean D, Pall E, Daradics Z, Popescu M, Tripon MA, Lupșan AF, Crecan CM, Morar IA, Nicolescu A, Bora FD, Marcus I.Musculoskeletal disorders are a major cause of lameness in horses, often necessitating innovative regenerative strategies to restore joint function and improve quality of life. This study investigated the effects of platelet-rich plasma (PRP), ozonized PRP, hyaluronic acid, paracetamol, and polyacrylamide hydrogel (NOLTREX) on the behavior of mesenchymal stem cells (MSCs) derived from equine synovial fluid. Synovial fluid samples were collected under strict cytological criteria to ensure viability, followed by in vitro expansion and phenotypic characterization of MSCs. Cultures were supplement...
Newly isolated bacteriophages show efficacy and phage-antibiotic synergy in vitro against the equine genital pathogens Klebsiella pneumoniae and Pseudomonas aeruginosa.
BMC veterinary research    October 3, 2025   Volume 21, Issue 1 568 doi: 10.1186/s12917-025-04989-1
Köhne M, Hüsch R, Peh E, Hirnet J, Tönissen A, Müsken M, Plötz M, Kittler S, Sieme H.Bacterial infections of the genital tract are a severe problem in equine reproduction. Biofilms produced by Klebsiella (K.) pneumoniae and Pseudomonas (P.) aeruginosa present further concerns in such cases as they can limit the success of antibiotic treatments. Alternative treatment approaches are urgently needed for treating bacterial equine genital tract infections and thus, reduce antibiotic use. The present study reports on the bactericidal efficacy of both, novel K. pneumoniae- and P. aeruginosa-specific phages, in a biofilm model and in conjunction with antibiotic drugs as tested in vitr...
Polysulfated glycosaminoglycan as a treatment for osteoarthritis in veterinary medicine: Summary of the pharmacological, laboratory, and clinical data.
Open veterinary journal    September 30, 2025   Volume 15, Issue 9 4007-4023 doi: 10.5455/OVJ.2025.v15.i9.6
White GW.Polysulfated glycosaminoglycan (PSGAG) is an antiarthritic drug that has been used in veterinary medicine for many years. PSGAG is rapidly distributed to diseased joint tissue after intraarticular or intramuscular administration, as shown in pharmacological studies conducted on a variety of animal species. In diseased joint tissue, PSGAG stimulates: 1) its own incorporation into the cartilage matrix, 2) inhibition of catabolic enzymes, 3) anabolic effects in the synovial and cartilage tissue, and 4) anti-inflammatory effects. Laboratory and clinical studies in humans, rabbits, horses, and dogs...
Adverse Effects and Drug Reactions in Equids.
The Veterinary clinics of North America. Equine practice    September 24, 2025   Volume 41, Issue 3 653-674 doi: 10.1016/j.cveq.2025.08.011
Wilson KE, Davis JL.Adverse drug events (ADEs) are any harms caused by medical interventions used for treatment, prevention, or diagnosis. These events can happen due to human error or as unintended, harmful reactions to drugs when given at normal therapeutic doses. This review focuses on common ADEs associated with drugs frequently used in equine practice. Recognizing and understanding the manifestations of ADEs can help with early detection and more effective management, ultimately leading to better outcomes for equine patients. Additionally, knowledge of the potential harmful effects of drugs also aids in appr...